We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Prolonged Fasting Promotes Immune System Regeneration

By LabMedica International staff writers
Posted on 17 Jun 2014
A new study suggest that prolonged cycles of fasting trigger stem-cell based regeneration of immune cells and the clearing out of old, damaged cells.

Researchers at the University of Southern California (USC; Los Angeles, USA), the University of Palermo (Italy), and other institutions have succeeded in demonstrating in a mouse model that fasting for 2–4 days at a time reduces circulating insulin-like growth factor 1 (IGF-1) levels and protein kinase A (PKA) activity in various cell populations, leading to signal transduction changes in long-term hematopoietic stem cells (LT-HSCs) and niche cells that promote stress resistance, self-renewal, and lineage-balanced regeneration. More...


The researchers also found that multiple cycles of fasting abated the immunosuppression and mortality caused by chemotherapy and reversed age-dependent myeloid-bias, supporting previous data on the protection of lymphocytes from chemotoxicity in fasting. The pro-regenerative effects of fasting on stem cells were reinforced by deficiency in either IGF-1 or PKA, and blunted by exogenous IGF-1. Prolonged fasting also protected against toxicity in a pilot clinical trial in which a small group of human patients fasted for a 72-hour period prior to chemotherapy. The study was published on June 5, 2014, in the journal Cell Stem Cell.

“Switching off the gene for PKA is the key step that triggers the stem cells to shift to regeneration; it gives the OK for stem cells to go ahead and begin proliferating and rebuild the entire system,” said corresponding author Prof. Valter Longo, PhD, director of the USC Longevity Institute. “The good news is that the body also rids itself of the parts of the system that might be damaged or old, the inefficient parts, during the fasting. If you start with a system heavily damaged by chemotherapy or aging, fasting cycles can generate, literally, a new immune system.”

According to the authors, the study has major implications for healthier aging, in which immune system decline contributes to increased susceptibility to disease as we age. By outlining how prolonged fasting cycles kill older and damaged immune cells and generate new ones, the research also has implications for chemotherapy tolerance and for those with a wide range of immune system deficiencies, including autoimmunity disorders.

Related Links:

University of Southern California
University of Palermo



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.